Case Report: Novel mutations in TBC1D24 are associated with autosomal dominant tonic-clonic and myoclonic epilepsy and recessive Parkinsonism, psychosis, and intellectual disability [version 1; referees: 2 approved]
Erika Banuelos,
Keri Ramsey,
Newell Belnap,
Malavika Krishnan,
Chris Balak,
Szabolcs Szelinger,
Ashley L. Siniard,
Megan Russell,
Ryan Richholt,
Matt De Both,
Ignazio Piras,
Marcus Naymik,
Ana M. Claasen,
Sampathkumar Rangasamy,
Matthew J. Huentelman,
David W. Craig,
Philippe M. Campeau,
Vinodh Narayanan,
Isabelle Schrauwen
Affiliations
Erika Banuelos
Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
Keri Ramsey
Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
Newell Belnap
Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
Malavika Krishnan
Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
Chris Balak
Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
Szabolcs Szelinger
Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
Ashley L. Siniard
Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
Megan Russell
Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
Ryan Richholt
Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
Matt De Both
Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
Ignazio Piras
Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
Marcus Naymik
Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
Ana M. Claasen
Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
Sampathkumar Rangasamy
Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
Matthew J. Huentelman
Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
David W. Craig
Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
Philippe M. Campeau
Department of Pediatrics, CHU Sainte-Justine Research Center and University of Montreal, Montreal, QC, H3T 1C5, Canada
Vinodh Narayanan
Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
Isabelle Schrauwen
Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA
Mutations disrupting presynaptic protein TBC1D24 are associated with a variable neurological phenotype, including DOORS syndrome, myoclonic epilepsy, early-infantile epileptic encephalopathy, and non-syndromic hearing loss. In this report, we describe a family segregating autosomal dominant epilepsy, and a 37-year-old Caucasian female with a severe neurological phenotype including epilepsy, Parkinsonism, psychosis, visual and auditory hallucinations, gait ataxia and intellectual disability. Whole exome sequencing revealed two missense mutations in the TBC1D24 gene segregating within this family (c.1078C>T; p.Arg360Cys and c.404C>T; p.Pro135Leu). The female proband who presents with a severe neurological phenotype carries both of these mutations in a compound heterozygous state. The p.Pro135Leu variant, however, is present in the proband’s mother and sibling as well, and is consistent with an autosomal dominant pattern linked to tonic-clonic and myoclonic epilepsy. In conclusion, we describe a single family in which TBC1D24 mutations cause expanded dominant and recessive phenotypes. In addition, we discuss and highlight that some variants in TBC1D24 might cause a dominant susceptibility to epilepsy